De-identified information allows HIPAA-covered entities to share patient data for extensive medical research, policy evaluations, comparative effectiveness research, and other experiments and analyses without violating patient privacy or necessitating patient consent before data can be disclosed.
It can be used or disclosed without restrictions as it neither identifies an individual nor offers a solid foundation.